Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05213923 · ClinicalTrials.gov registry record · NA
ED Tracking Sheet Implementation
A NA study, sponsored by Dartmouth-Hitchcock Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 194
- Enrollment target
NCT05213923 is a NA study that has completed, run by Dartmouth-Hitchcock Medical Center. The registered enrollment target is 194 participants.
The verdict
NCT05213923, a NA study, has completed, sponsored by Dartmouth-Hitchcock Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 194 participants
- Enrollment target
Study Summary
The purpose of this study is to assess whether implementation of an ED Sepsis Tracking Sheet effects the percentage of goal-directed sepsis criteria met in a tertiary care academic Emergency Department.
Interventions
- PROCEDURE ED Sepsis Tracking Sheet
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 194 participants |
| Start Date | 2021-07-01 |
| Est. Completion | 2022-06-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05213923
The ClinicalTrials.gov registry entry for NCT05213923 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 194 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Dartmouth-Hitchcock Medical Center, which has 427 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which ED Sepsis Tracking Sheet is the first listed.
NCT05213923 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05213923 about?
NCT05213923 is a clinical study titled "ED Tracking Sheet Implementation". The purpose of this study is to assess whether implementation of an ED Sepsis Tracking Sheet effects the percentage of goal-directed sepsis criteria met in a tertiary care academic Emergency Department.
What is the current status of trial NCT05213923?
This trial is currently completed. It is a NA study. The enrollment target is 194 participants. The study started on 2021-07-01. Estimated completion is 2022-06-01.
What interventions are being tested in trial NCT05213923?
The interventions under investigation include: ED Sepsis Tracking Sheet (PROCEDURE).
Who is sponsoring clinical trial NCT05213923?
This trial is sponsored by Dartmouth-Hitchcock Medical Center, which has 427 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.